148 related articles for article (PubMed ID: 8005206)
1. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test.
Steiner H; Bähr V; Exner P; Oelkers PW
Exp Clin Endocrinol; 1994; 102(1):33-8. PubMed ID: 8005206
[TBL] [Abstract][Full Text] [Related]
2. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
de Lange WE; Sluiter WJ
Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
[TBL] [Abstract][Full Text] [Related]
3. Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency.
Endert E; Ouwehand A; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2005 Dec; 63(11):435-43. PubMed ID: 16397312
[TBL] [Abstract][Full Text] [Related]
4. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests.
Giordano R; Picu A; Bonelli L; Balbo M; Berardelli R; Marinazzo E; Corneli G; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2008 Jun; 68(6):935-41. PubMed ID: 18031311
[TBL] [Abstract][Full Text] [Related]
6. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
Kinsley BT; Simonson DC
J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
[TBL] [Abstract][Full Text] [Related]
8. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
[TBL] [Abstract][Full Text] [Related]
9. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?
Dickstein G
J Endocrinol Invest; 2003; 26(7 Suppl):25-30. PubMed ID: 14604063
[TBL] [Abstract][Full Text] [Related]
10. Dynamic evaluation of adrenal hypofunction.
Nieman LK
J Endocrinol Invest; 2003; 26(7 Suppl):74-82. PubMed ID: 14604069
[TBL] [Abstract][Full Text] [Related]
11. [Metyrapone test and plasma hormone estimations (author's transl)].
Ducassou D; Rashedi M; Brendel A; Gasparoux S
Pathol Biol (Paris); 1977 Dec; 25(10):729-33. PubMed ID: 206869
[TBL] [Abstract][Full Text] [Related]
12. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.
Tordjman K; Jaffe A; Grazas N; Apter C; Stern N
J Clin Endocrinol Metab; 1995 Apr; 80(4):1301-5. PubMed ID: 7714104
[TBL] [Abstract][Full Text] [Related]
13. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
Golier JA; Schmeidler J; Yehuda R
Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone.
Hartzband PI; Van Herle AJ; Sorger L; Cope D
J Endocrinol Invest; 1988 Dec; 11(11):769-76. PubMed ID: 2852194
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.
Tuchelt H; Dekker K; Bähr V; Oelkers W
Clin Endocrinol (Oxf); 2000 Sep; 53(3):301-7. PubMed ID: 10971446
[TBL] [Abstract][Full Text] [Related]
16. Improved single-dose metyrapone test.
Dickstein G; Barzilai D
Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
[TBL] [Abstract][Full Text] [Related]
17. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.
Mayenknecht J; Diederich S; Bähr V; Plöckinger U; Oelkers W
J Clin Endocrinol Metab; 1998 May; 83(5):1558-62. PubMed ID: 9589655
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
Nelson JC; Tindall DJ
Am J Med Sci; 1978; 275(2):165-72. PubMed ID: 208417
[TBL] [Abstract][Full Text] [Related]
19. The short metyrapone test: comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced hypoglycaemia in patients with pituitary disease.
Feek CM; Bevan JS; Ratcliffe JG; Gray CE; Blundell G
Clin Endocrinol (Oxf); 1981 Jul; 15(1):75-80. PubMed ID: 6273024
[TBL] [Abstract][Full Text] [Related]
20. Quadruple injection of hypothalamic peptides to evaluate pituitary function in normal subjects.
Kaltenborn KC; Jubiz W
West J Med; 1985 Jan; 142(1):37-41. PubMed ID: 3919507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
